Business Description
Founded in 1999 and based in Bresso, Italy, Newron Pharmaceuticals is a drug development company focused on disorders of the nervous system, operating across Europe, the United States, and other major markets. Its approved product, Xadago, is used to treat Parkinson's disease and is sold in multiple countries through partnerships with Zambon and Meiji Seika Pharma. The company is advancing two additional treatments ? one for schizophrenia currently in late-stage trials, and another targeting rare nerve pain conditions.
